Skip to main content

Fidelity — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

258
Companies
$33.3B
Total invested
$152.8M
Avg. check
54
Industries
Biotechnology 11Health Care 6Therapeutics 5Automotive 4Biopharma 3Electric Vehicle 3+48 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 73–96 of 258
JUUL
November 2023

JUUL is a manufacturer and distributor of electronic nicotine vaporizers.

B2C · San Francisco$1.3B Venture - Series Unknown
GO
October 2023

GO is a developer of both software and hardware in the field of transportation and mobility based on a taxi system.

Automotive · TokyoSeries D
Evozyne
September 2023

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Artificial Intelligence (AI) · Chicago$81.0M Series B
Poseida Therapeutics
August 2023

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Biopharma · San Diego$25.0M Post-IPO Equity
QuantumScape
August 2023

QuantumScape develops solid-state lithium-metal batteries for electric vehicles and other energy storage applications.

Automotive · San Jose$300.0M Post-IPO Equity
GenePlanet
July 2023

GenePlanet is a European company active in the field of biotechnology, specializing in genetic testing and research.

Biotechnology · Ljubljana$22.4M Series B
Moloco
June 2023

Moloco offers programmatic advertising solutions to help optimize the client's acquisition, retention, and monetization campaigns.

Advertising · Redwood City$24.2M Series D
Cyxtera Technologies
June 2023

Cyxtera Technologies provides an integrated, secure, and resilient infrastructure platform.

Analytics · Coral Gables$200.0M Post-IPO Debt
ElevateBio
May 2023

ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.

Alternative Medicine · Waltham$401.0M Series D
Ikena Oncology
May 2023

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

Biotechnology · Boston$40.0M Post-IPO Equity
Smart
May 2023

Smart is a savings and investments technology platform provider.

Financial Services · London$95.0M Series E
CelLink
May 2023

High-conductance, large-area flexible circuits for the clean power revolution.

Electric Vehicle · San Carlos$362.0M Debt Financing
Gridwealth
April 2023

Gridwealth lowers GHG emissions while generating long-term cash for customer buildings.

Manufacturing · Boston$30.0M Venture - Series Unknown
Generation Bio
March 2023

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Biotechnology · Cambridge$76.0M Post-IPO Equity
Omega Therapeutics
February 2023

Omega Therapeutics offers a proprietary epigenomic programming platform.

Biotechnology · Cambridge$40.0M Post-IPO Equity
Blue Apron
February 2023

Blue Apron is a grocery delivery service company that offers fresh, chef-designed recipes to customers.

Delivery · New York$70.0M Post-IPO Equity
AppHarvest
February 2023

AppHarvest is a sustainability company that operates and develops robust, climate-resilient indoor farms.

Agriculture · Morehead$46.0M Post-IPO Equity
Moonfare
February 2023

Moonfare is a digital platform that provides HNWI, family offices, banks and their advisors access to top-tier private markets investments.

Asset Management · Berlin$15.0M Series C
Roivant Sciences
February 2023

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

Biopharma · New York$230.0M Post-IPO Equity
Inscripta
January 2023

Inscripta is a life science technology company that develops digital genome engineering solutions.

Biotechnology · Pleasanton$4.4M Venture - Series Unknown
Asimov
January 2023

Asimov employs artificial intelligence to develop tools for the design and manufacture of next-generation therapeutics.

Artificial Intelligence (AI) · Boston$175.0M Series B
Astera Labs
November 2022

Astera Labs is a semiconductor company that provides connectivity solutions for intelligent systems.

AI Infrastructure · San Jose$150.0M Series D
Nu Ride
November 2022

Nu Ride is a company expanding into insurance distribution and wealth advisory services through acquisitions.

Automotive · New York$170.0M Post-IPO Equity
Emalex Biosciences
November 2022

Emalex Biosciences is a biotech startup that develops new treatments for central nervous system disorders.

Biopharma · Chicago$270.0M Series D

Where Fidelity invests

Biotechnology11
Health Care6
Therapeutics5
Automotive4
Biopharma3
Electric Vehicle3

About Fidelity's portfolio

How many companies has Fidelity invested in?▸

Fidelity has invested in 258 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Fidelity invest in?▸

Fidelity's top investment sectors include Biotechnology, Health Care, Therapeutics, Automotive, Biopharma. The firm invests across 54 different industry categories.

What is Fidelity's largest investment?▸

Among tracked funding rounds, JUUL received $1.3B in a Venture - Series Unknown round. Fidelity's total known invested capital is $33.3B.

What is the average investment size for Fidelity?▸

Fidelity's average investment size is $152.8M across its portfolio of 258 companies.

What are Fidelity's most recent investments?▸

Recent Fidelity portfolio additions include JUUL, GO, Evozyne, Poseida Therapeutics, QuantumScape. These companies were founded in 2020 or later.

Reach the founders behind these 258 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →